View graph of relations
  1. 2019
  2. Published
  3. Published
  4. Published
  5. Published
  6. Published
  7. Published
  8. Published
  9. Published
    Zoubek, M. E., Woitok, M. M., Sydor, S., Nelson, L. J., Bechmann, L. P., Lucena, M. I., ... Cubero, F. J. (2019). Protective role of c-Jun N-terminal kinase-2 (JNK2) in ibuprofen-induced acute liver injury. Journal of Pathology, 247(1), 110-122. https://doi.org/10.1002/path.5174
  10. Published
  11. 2018
  12. Published
  13. Published
  14. Published
  15. Published
  16. Published
    Leak, R. K., Calabrese, E. J., Kozumbo, W. J., Gidday, J. M., Johnson, T. E., Mitchell, J. R., ... Andersen, M. E. (2018). Enhancing and Extending Biological Performance and Resilience. Dose-Response, 16(3), [1559325818784501]. https://doi.org/10.1177/1559325818784501
  17. Published
  18. Published
  19. Published
  20. Published
  21. Published
  22. Published
  23. Published
  24. 2017
  25. Published
  26. Published
  27. Published
  28. Published
  29. Published
  30. Published
  31. Published
  32. Published
  33. Published
  34. Published
  35. Published
  36. Published
  37. 2016
  38. Published
  39. Published
  40. Published
  41. Published
  42. Published
    Heyninck, K., Sabbe, L., Chirumamilla, C. S., Szic, K. S. V., Veken, P. V., Lemmens, K. J. A., ... Berghe, W. V. (2016). Withaferin A induces heme oxygenase (HO-1) expression in endothelial cells via activation of the Keap1/Nrf2 pathway. Biochemical Pharmacology, 109, 48-61. https://doi.org/10.1016/j.bcp.2016.03.026
  43. Published
  44. Published
  45. Published
  46. Published
  47. Published
  48. 2015
  49. Published
  50. Published
  51. Published
  52. Published
  53. Published
  54. Published
  55. Published
  56. Published
  57. Published
  58. Published
  59. Published
  60. Published
  61. Published
    Boesten, D. M. P. H. J., den Hartog, G. J. M., de Cock, P., Bosscher, D., Bonnema, A., & Bast, A. (2015). Health effects of erythritol. Nutrafoods, 14, 3-9. https://doi.org/10.1007/s13749-014-0067-5
  62. Published
  63. Published
  64. Published
  65. Published
  66. Published
  67. Published
    Rezk, B., van der Vijgh, W. J. F., Bast, A., & Haenen, G. R. (2015). Toxicity of Antioxidants. Toxicology and Forensic Medicine, 1(1), [1000TFMOJ1e002].
  68. Published
  69. Published
  70. Published
    Bast, A., & Haenen, G. (2015). Nutritional Antioxidants: It Is Time to Categorise. In M. Lamprecht (Ed.), Antioxidants in Sport Nutrition (pp. 17-38). Boca Raton: CRC Press, Taylor & Frances Group.
  71. Published
  72. 2014
  73. Published
  74. Published
  75. Published
  76. Published
  77. Published
  78. Published
  79. Published
  80. Published
  81. Published
  82. Published
  83. Published
  84. Published
  85. Published
    Weseler, A. R., & Bast, A. (2014). Nutritional components: How they enhance the ability to adapt. In S. I. S. Rattan, & E. Le Bourg (Eds.), Hormesis in health and disease (pp. 45-78). Boca Raton: CRC Press, Taylor & Frances Group.
  86. Published
    Drent, M., Bast, A., & Bootsma, H. P. (2014). 'Oude' medicijnen kans voor zeldzame ziekten. Medisch Contact, 5 juni(6), 1153-1155.
  87. Published
  88. Published
  89. Published
  90. 2013
  91. Published
  92. Published
  93. Published
  94. Published
  95. Published
  96. Published
  97. Published
  98. Published
  99. Published
  100. Published
  101. Published
  102. Published
    Bast, A., Briggs, W., Calabrese, E., Fenech, M., Hanekamp, J. C., Heaney, R., ... Verhoeven, P. (2013). Scientism, Legalism and Precaution - Contending with Regulating Nutrition and Health Claims in Europe. European Food and Feed Law Review, 6(2013), 401-409.
  103. Published
  104. Published
  105. Published
  106. Published
  107. 2012
  108. Published
  109. Published
  110. Published
  111. Published
  112. Published
  113. Published
  114. Published
  115. Published
  116. Published
  117. Published
    Weseler, A. R., & Bast, A. (2012). Effects of flavonoids on the vascular endothelium: What is known and what is next? In J. P. E. Spencer, & A. Crozier (Eds.), Flavonoids and related compounds. Bioavailability and function. (pp. 309-330). CRC Press.
  118. Published
  119. Published
  120. Published
  121. Published
  122. Published
  123. Published
  124. Published
  125. Published
  126. 2011
  127. Published
  128. Published
  129. Published
  130. Published
  131. Published
  132. Published
  133. Published
  134. Published
  135. Published
  136. Published
  137. Published
  138. Published
  139. Published
  140. 2010
  141. Published
  142. Published
  143. Published
  144. Published
  145. Published
  146. Published
  147. Published
  148. Published
  149. Published
    Drent, M., Dekhuijzen, P. N., Grutters, J. C., Bresser, P., van der Bij, W., & Bast, A. (2010). Antioxidant moet vergoed blijven. N-acetylcysteïne belangrijk voor longfibrosepatiënten. Medisch Contact, 65(1), 30-33.
  150. Published
  151. Published
  152. Published
  153. Published
  154. Published
  155. Published
  156. Published
  157. Published
    Wolf, G., Aumann, N., Michalska, M., Bast, A., Sonnemann, J., Beck, J. F., ... Walther, R. (2010). Peroxiredoxin III protects pancreatic {beta} cells from apoptosis. Journal of Endocrinology, 207(2), 163-175. https://doi.org/10.1677/JOE-09-0455
  158. Published
  159. 2009
  160. Published
  161. Published
  162. Published
  163. Published
  164. Published
  165. Published
    Jacobs, H., van der Vijgh, W. J., Koek, G. H., Draaisma, G. J., Moalin, M., van Strijdonck, G. P., ... Haenen, G. R. (2009). Characterization of the glutathione conjugate of the semisynthetic flavonoid monoHER. Free Radical Biology and Medicine, 46(12), 1567-1573. https://doi.org/10.1016/j.freeradbiomed.2009.02.031
  166. Published
  167. Published
  168. Published
  169. Published
  170. Published
  171. Published
  172. Published
  173. Published
  174. Published
  175. 2008
  176. Published
  177. Published
  178. Published
  179. Published
  180. Published
  181. Published
  182. Published
  183. Published
  184. Published
  185. Published
  186. Published
  187. Published
  188. Published
  189. 2007
  190. Published
  191. Published
  192. Published
  193. Published
  194. Published
    Bruynzeel, A. M., Abou el Hassan, M. A., Torun, E., Bast, A., van der Vijgh, W. J., & Kruyt, F. A. (2007). Caspase-dependent and -independent suppression of apoptosis by monoHER in Doxorubicin treated cells. British Journal of Cancer, 96(3), 450-456. https://doi.org/10.1038/sj.bjc.6603598
  195. Published
  196. Published
  197. Published
  198. Published
  199. Published
  200. Published
  201. Published
  202. Published
  203. Published
    Koek, G. H., Bast, A., & Driessen, A. (2007). Liver cirrhosis and vitaminE status. In V. R. Preedy, & R. R. Watson (Eds.), The Encyclopedia of vitamin E. (pp. 773-781). CAB International.
  204. Published
  205. Published
  206. Published
  207. Published
  208. Published
  209. Published
  210. Published
  211. Published
  212. Published
  213. Published
  214. Published
  215. Published
    Bruynzeel, A. M., Niessen, H. W. M., Bronzwaer, J. G., van der Hoeven, J. J., Berkhof, J., Bast, A., ... van Groeningen, C. J. (2007). The effect of monohydroxyethylrutoside on doxorubicin-induced cardiotoxicity in patients treated for metastatic cancer in a phase II study. British Journal of Cancer, 97(8), 1084-1089. https://doi.org/10.1038/sj.bjc.6603994
  216. Published
  217. Published
  218. Published
  219. Published
    Bast, A., & van den Berg, H. (2007). Voedingssupplementen. In J. J. E. V. Everdingen, & J. H. Glerum (Eds.), Diagnose en therapie Jaarboek 2007. (pp. 1179-1205). Bohn Stafleu van Loghum.
  220. 2006
  221. Published
    Willems, A. M., Bruynzeel, A. M., Kedde, M. A., van Groeningen, C. J., Bast, A., & van der Vijgh, W. J. F. (2006). A phase I study of monohydroxyethylrutoside in healthy volunteers. Cancer Chemotherapy and Pharmacology, 57(5), 678-684. https://doi.org/10.1007/s00280-005-0083-7
  222. Published
  223. Published
  224. Published
  225. Published
  226. Published
  227. Published
  228. Published
  229. Published
  230. Published
  231. Published
  232. Published
    Bast, A., & van den Berg, H. (2006). Voedingssuplementen. In E. E. V. Everdingen, & J. H. Glerum (Eds.), Diagnose en therapie Jaarboek 2006 (pp. 1147-1172). Bohn Stafleu van Loghum.
  233. 2005
  234. Published
  235. Published
  236. Published
  237. Published
  238. Published
  239. Published
  240. Published
    Michels, G., Watjen, W., Niering, P., Steffan, B., Thi, Q. H., Chovolou, Y., ... Kahl, R. (2005). Pro-apoptotic effects of the flavonoid luteolin in rat H4IIE cells. Toxicology, 206(3), 337-348. https://doi.org/10.1016/j.tox.2004.07.022
  241. Published
  242. Published
  243. Published
  244. 2004
  245. Published
  246. Published
  247. Published
    Bast, A., & Haenen, G. R. M. M. (2004). Dose-response relationships with special refrence to antioxidants. In Commission Food Safety, & G. Eisenbrand (Eds.), Functional food: Safety aspects (pp. 98-111). Deutsche Forschungsgemeinschaft.
  248. Published
    de Franceschi, L., Turrini, F., Honczarenko, M., Ayi, K., Rivera, A., Fleming, M. D., ... Brugnara, C. (2004). In vivo reduction of erythrocyte oxidant stress in a murine model of beta-thalassemia. Haematologica-the Hematology Journal, 89(11), 1287-1298.
  249. Published
  250. Published
  251. Published
  252. Published
  253. Published
  254. Published
  255. Published
  256. Published
    Bast, A., & van den Berg, H. (2004). Voedingssupplementen en vitamines. In Therapie Informatorium Houten: Bohn, Stafleu en Van Loghum.
  257. 2003
  258. Published
  259. Published
  260. Published
  261. Published
  262. Published
  263. Published
  264. Published
  265. Published
  266. Published
  267. Published
  268. Published
  269. Published
  270. Published
  271. Published
  272. Published
  273. Published
  274. Published
  275. Published
  276. Published
  277. Published
  278. Published
    Bast, A. (2003). The risk of eating: the toxicity of natural versus man-made chemicals. In G. Voss, & G. Ramos (Eds.), Chemistry of crop protection (pp. 63-68). Wiley-VCH Verlag.
  279. Published
  280. 2002
  281. Published
    Stahl, W., van den Berg, H., Arthur, J., Bast, A., Dainty, J., Faulks, R. M., ... et, A. (2002). Bioavailability and metabolism. Molecular Aspects of Medicine, 23(1-3), 39-100. https://doi.org/10.1016/S0098-2997(02)00016-X
  282. Published
    Griffiths, H. R., Moller, L., Bartosz, G., Bast, A., Bertoni-Freddari, C., Collins, A., ... Verhagen, H. (2002). Biomarkers. Molecular Aspects of Medicine, 23(1-3), 101-108. https://doi.org/10.1016/S0098-2997(02)00017-1
  283. Published
    Bast, A., Chandler, R. F., Choy, P. C., Delmulle, L. M., Gruenwald, J., Halkes, S. B. A., ... Vermeer, I. T. M. (2002). Botanical health products, positioning and requirements for effective and safe use. Environmental Toxicology and Pharmacology, 12, 195-211. https://doi.org/10.1016/S1382-6689(02)00035-2
  284. Published
  285. Published
    van Schooten, F. J., Besarati Nia, A., de Flora, S., D'Agostini, F., Izzotti, A., Camoirano, A., ... et, A. (2002). Effects of oral administration of N-acetyl-L-cysteine: a multi-biomarker study in smokers. Cancer Epidemiology Biomarkers & Prevention, 11(2), 167-175.
  286. Published
  287. Published
  288. Published
  289. Published
  290. Published
  291. Published
    Bast, A., & Haenen, G. R. M. M. (2002). Lipoic acid: a multifunctional antioxidant. In A. Pompella, G. Banhegyi, & M. Wellma-Rousseau (Eds.), Thiol metabolism and redix regulation of cellular functions (pp. 230-237). Amsterdam/Berlin/Oxford/Tokyo/Washington DC: IOS Press.
  292. Published
  293. Published
  294. Published
  295. Published
  296. Published
  297. Published
  298. Published
  299. Published
  300. 2001
  301. Published
    van den Berg, R., van Vliet, T., Broekmans, W. M. R., Cnubben, N. H. P., Vaes, W. H. J., Roza, L., ... van den Berg, H. (2001). A vegetable/fruit concentrate with high antioxidant capacity has no effect on biomarkers of antioxidant status in male smokers. Journal of Nutrition, 131, 1714-1722. https://doi.org/10.1093/jn/131.6.1714
  302. Published
  303. Published
  304. Published
  305. Published
  306. Published
  307. Published
  308. Published
  309. Published
  310. Published
  311. Published
    Nemery, B., Bast, A., Behr, J., Borm, P. J. A., Bourke, S., Camus, P., ... Saltini, C. (2001). Interstitial lung disease induced by exogenous agents: factors governing susceptibility. European Respiratory Journal, 18 supp 12, 30s-42s.
  312. Published
    Bast, A., & Haenen, G. R. M. M. (2001). Lipoic acid: A multifunctional nutraceutical. In K. Kramer, PP. Hoppe, & L. Packer (Eds.), Nutraceuticals in health and disease prevention New York / Basel: Marcel Dekker Inc..
  313. Published
  314. Published
  315. Published
  316. Published
  317. Published
  318. Published
  319. Published
  320. Published
  321. Published
  322. Published
  323. 2000
  324. Published
  325. Published
  326. Published
  327. Published
  328. Published
    van Acker, F. A. A., van Acker, S. A. B. E., Haenen, G. R. M. M., Bast, A., & van der Vijgh, W. J. F. (2000). In vitro screening of antitumour agents for cardiotoxicity by means of isolated mouse left atria. Anticancer Research, 20, 4483-4488.
  329. Published
    Westerveld, G. J., Voss, H. P., van der Hee, R. M., de Haan-Koelewijn, G. J. N., den Hartog, G. J. M., Scheeren, R. A., & Bast, A. (2000). Inhibition of nitric oxide synthase by nasal decongestants. European Respiratory Journal, 16, 437-444. https://doi.org/10.1034/j.1399-3003.2000.016003437.x
  330. Published
  331. Published
  332. Published
  333. Published
  334. Published
  335. Published
  336. Published
  337. Published
  338. Published
  339. 1999
  340. Published
  341. Published
  342. Published
  343. Published
  344. 1998
  345. Published
  346. Published
  347. Published